Soleus Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,400,000
Closed -$114M 103
2025
Q1
$114M Sell
1,400,000
-1,600,000
-53% -$143M 8.17% 1
2024
Q4
$270M Buy
3,000,000
+2,100,000
+233% +$203M 16.98% 1
2024
Q3
$88.9M Buy
+900,000
New +$88.4M 6.89% 1
2023
Q4
Sell
-1,250,000
Closed -$91.3M 103
2023
Q3
$91.3M Buy
+1,250,000
New +$99.8M 8.42% 1
2023
Q2
Sell
-2,080,000
Closed -$159M 109
2023
Q1
$159M Buy
+2,080,000
New +$173M 16.42% 1
2022
Q2
Sell
-1,408,100
Closed -$127M 84
2022
Q1
$127M Buy
+1,408,100
New +$130M 16.33% 1

Other funds holding XBI